The Supreme Court has turned away an opioid case against Purdue and the Sackler family. The Arizona lawsuit aims to stop the Sacklers from transferring money out of Purdue Pharma to avoid paying claims over its opioid OxyContin. (CNN)
The White House has endorsed a bipartisan deal to curb consumer health costs. The deal would bring about legislation to curb surprise medical bills, provide money to community health centers, limit drug price increases and raise the age to buy tobacco products. (Associated Press)
Sanofi and Merck have both bought cancer-focused drugmakers. Sanofi will acquire Synthorx, a San Diego company focused on developing cancer drugs using synthetic DNA. Merck will acquire Massachusetts company ArQule for $2.7 billion. (STAT)
Hospital network is planning to cut opioid prescriptions by 40%. Intermountain Healthcare, a Utah hospital chain, will use a “data-driven approach” to track prescriptions and develop new guidelines for opioid prescribing. (CNBC)
Roche has extended its offer to take over Spark Therapeutics. The offer was extended again to allow U.S. and U.K. regulators to complete their reviews of the deal. Roche will pay $4.3 billion for the Philadelphia gene therapy company. (MarketWatch)
